Format

Send to

Choose Destination
J Gen Intern Med. 2019 Apr;34(4):518-520. doi: 10.1007/s11606-018-4752-8.

Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017.

Author information

1
Yale School of Medicine, New Haven, CT, USA.
2
Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA.
3
Section of General Internal Medicine, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
4
Department of Health Policy and Management, School of Public Health, Yale University, New Haven, CT, USA.
5
Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN, USA.
6
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
7
San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA. sanket.dhruva@ucsf.edu.
8
Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, USA. sanket.dhruva@ucsf.edu.
PMID:
30623386
PMCID:
PMC6445908
[Available on 2020-04-01]
DOI:
10.1007/s11606-018-4752-8

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center